RxDoctor Payments Data

Cody Hanson, DO

Dermatology · Saint Joseph, MONPI 1306230784

Payments from drug & device makers

$1,442in general payments, 2019–2025

Across 52 payments — averaging $27.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$655
  • Bristol Myers Squibb$147
  • Johnson & Johnson$140
  • Amgen$100
  • LEO Pharma Inc.$68
  • Lilly USA, LLC$49
  • plus $284 from 11 others

What the payments were for

  • Food & beverage$1,442100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,442 in reported general payments places this provider in the 25th percentile of 263 dermatology providers in Missouri.

See all dermatology providers in Missouri

Medicare billing

Part B allowed, 2024
$157,952
Medicare patients
830
Services billed
3,613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa15$346,098
Humira(Cf) PenAdalimumab19$273,358
Dupixent PenDupilumab46$187,476
OtezlaApremilast30$159,972
Ketoconazole136$2,690
Fluorouracil34$2,300
Doxycycline Monohydrate24$2,067
Clobetasol Propionate41$1,446
Doxycycline Hyclate48$1,045
Clindamycin Phosphate23$712
Imiquimod12$703
Ciclopirox22$636
ValacyclovirValacyclovir Hcl17$506
CiclopiroxCiclopirox Olamine13$440
Triamcinolone Acetonide46$426

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$100$159,97230 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 263 dermatology providers in Missouri.

Other dermatology in Saint Joseph

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →